Abt E, Carr AB, Worthington HV Interventions for replacing missing teeth: partially absent dentition. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003814. doi: 10.1002/14651858.CD003814.pub2. Review.
Batson ER, Cooper LF, Duqum I, Mendonça G Clinical outcomes of three different crown systems with CAD/CAM technology. J Prosthet Dent. 2014 Oct;112(4):770-7. doi: 10.1016/j.prosdent.2014.05.002. Epub 2014 Jun 28.
Denry I, Kelly JR Emerging ceramic-based materials for dentistry. J Dent Res. 2014 Dec;93(12):1235-42. doi: 10.1177/0022034514553627. Epub 2014 Oct 1. Review.
Donovan TE Factors essential for successful all-ceramic restorations. J Am Dent Assoc. 2008 Sep;139 Suppl:14S-18S. Review.
Douglass CW, Watson AJ Future needs for fixed and removable partial dentures in the United States. J Prosthet Dent. 2002 Jan;87(1):9-14.
Ettinger RL, Goettsche ZS, Qian F The Extent and Scope of Prosthodontic Practice in Iowa. J Prosthodont. 2019 Feb;28(2):113-121. doi: 10.1111/jopr.12588. Epub 2017 Mar 8.
Flinn BD, Raigrodski AJ, Mancl LA, Toivola R, Kuykendall T Influence of aging on flexural strength of translucent zirconia for monolithic restorations. J Prosthet Dent. 2017 Feb;117(2):303-309. doi: 10.1016/j.prosdent.2016.06.010. Epub 2016 Sep 22.
Harada K, Raigrodski AJ, Chung KH, Flinn BD, Dogan S, Mancl LA A comparative evaluation of the translucency of zirconias and lithium disilicate for monolithic restorations. J Prosthet Dent. 2016 Aug;116(2):257-63. doi: 10.1016/j.prosdent.2015.11.019. Epub 2016 Mar 17.
Johansson C, Kmet G, Rivera J, Larsson C, Vult Von Steyern P Fracture strength of monolithic all-ceramic crowns made of high translucent yttrium oxide-stabilized zirconium dioxide compared to porcelain-veneered crowns and lithium disilicate crowns. Acta Odontol Scand. 2014 Feb;72(2):145-53. doi: 10.3109/00016357.2013.822098. Epub 2013 Jul 18.
Kancyper S, Sierraalta M, Razzoog ME All-ceramic surveyed crowns for removable partial denture abutments. J Prosthet Dent. 2000 Oct;84(4):400-2.
Kelly JR Dental ceramics: what is this stuff anyway? J Am Dent Assoc. 2008 Sep;139 Suppl:4S-7S.
Koyama S, Sasaki K, Yokoyama M, Sasaki T, Hanawa S Evaluation of factors affecting the continuing use and patient satisfaction with Removable Partial Dentures over 5 years. J Prosthodont Res. 2010 Apr;54(2):97-101. doi: 10.1016/j.jpor.2009.11.007. Epub 2010 Jan 18.
Larsson C, Wennerberg A The clinical success of zirconia-based crowns: a systematic review. Int J Prosthodont. 2014 Jan-Feb;27(1):33-43. doi: 10.11607/ijp.3647. Review.
Le M, Papia E, Larsson C The clinical success of tooth- and implant-supported zirconia-based fixed dental prostheses. A systematic review. J Oral Rehabil. 2015 Jun;42(6):467-80. doi: 10.1111/joor.12272. Epub 2015 Jan 10. Review.
Murai S, Matsuda K, Ikebe K, Enoki K, Hatta K, Fujiwara K, Maeda Y A field survey of the partially edentate elderly: Investigation of factors related to the usage rate of removable partial dentures. J Oral Rehabil. 2015 Nov;42(11):828-32. doi: 10.1111/joor.12318. Epub 2015 Jun 7.
Nordahl N, Vult von Steyern P, Larsson C Fracture strength of ceramic monolithic crown systems of different thickness. J Oral Sci. 2015 Sep;57(3):255-61. doi: 10.2334/josnusd.57.255.
Ozer F, Mante FK, Chiche G, Saleh N, Takeichi T, Blatz MB A retrospective survey on long-term survival of posterior zirconia and porcelain-fused-to-metal crowns in private practice. Quintessence Int. 2014 Jan;45(1):31-8. doi: 10.3290/j.qi.a30768.
Ozkurt Z, Kazazoglu E Clinical success of zirconia in dental applications. J Prosthodont. 2010 Jan;19(1):64-8. doi: 10.1111/j.1532-849X.2009.00513.x. Epub 2009 Sep 14. Review.
Pihlaja J, Näpänkangas R, Kuoppala R, Raustia A Veneered zirconia crowns as abutment teeth for partial removable dental prostheses: a clinical 4-year retrospective study. J Prosthet Dent. 2015 Nov;114(5):633-6. doi: 10.1016/j.prosdent.2015.05.008. Epub 2015 Sep 4.
Raigrodski AJ Contemporary materials and technologies for all-ceramic fixed partial dentures: a review of the literature. J Prosthet Dent. 2004 Dec;92(6):557-62. Review.
Rehmann P, Orbach K, Ferger P, Wöstmann B Treatment outcomes with removable partial dentures: a retrospective analysis. Int J Prosthodont. 2013 Mar-Apr;26(2):147-50. doi: 10.11607/ijp.2959.
Sailer I, Makarov NA, Thoma DS, Zwahlen M, Pjetursson BE All-ceramic or metal-ceramic tooth-supported fixed dental prostheses (FDPs)? A systematic review of the survival and complication rates. Part I: Single crowns (SCs). Dent Mater. 2015 Jun;31(6):603-23. doi: 10.1016/j.dental.2015.02.011. Epub 2015 Apr 2. Review. Erratum in: Dent Mater. 2016 Dec;32(12 ):e389-e390.
Slade GD, Spencer AJ Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994 Mar;11(1):3-11.
Slade GD Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997 Aug;25(4):284-90.
Spear F, Holloway J Which all-ceramic system is optimal for anterior esthetics? J Am Dent Assoc. 2008 Sep;139 Suppl:19S-24S. Review.
Stober T, Bermejo JL, Rammelsberg P, Schmitter M Enamel wear caused by monolithic zirconia crowns after 6 months of clinical use. J Oral Rehabil. 2014 Apr;41(4):314-22. doi: 10.1111/joor.12139. Epub 2014 Jan 22.
Sulaiman TA, Abdulmajeed AA, Donovan TE, Cooper LF, Walter R Fracture rate of monolithic zirconia restorations up to 5 years: A dental laboratory survey. J Prosthet Dent. 2016 Sep;116(3):436-9. doi: 10.1016/j.prosdent.2016.01.033. Epub 2016 May 11. Erratum in: J Prosthet Dent. 2017 Jan;117(1):195.
Yoon TH, Chang WG The fabrication of a CAD/CAM ceramic crown to fit an existing partial removable dental prosthesis: a clinical report. J Prosthet Dent. 2012 Sep;108(3):143-6. doi: 10.1016/S0022-3913(12)60137-1.
Removable Partial Denture Abutments Restored With Monolithic Zirconia Crowns: A Randomized Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
